Login / Signup

Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study.

Hanmei LouHongbing CaiXin HuangGuiling LiLi WangFei LiuWenjing QinTing LiuWei LiuZhongmin Maxwell WangBaiyong LiYu XiaJing Wang
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Cadonilimab combined with standard therapy was acceptable, with encouraging antitumor activity in patients with R/M CC.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • stem cells
  • randomized controlled trial
  • clinical trial
  • double blind
  • cell therapy
  • study protocol
  • placebo controlled